drugset / Trial / NCT00006114

Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00006114

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Timeline

Start
1999-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitoxantrone Small molecule Intravenous
Subject Vinorelbine Small molecule Intravenous

Indications